The CLL12 trial: Ibrutinib versus placebo in treatment-naive, early stage chronic lymphocytic leukemia. Langerbeins P, Zhang C, Robrecht S, Cramer P, et al. Blood 2021 Nov 10. pii: 477942. doi: 10.1182/blood.2021010845.

Read + Share

Amedeo Smart

Independent Medical Education

Langerbeins P, Zhang C, Robrecht S, Cramer P, et al. The CLL12 trial: Ibrutinib versus placebo in treatment-naive, early stage chronic lymphocytic leukemia. Blood 2021 Nov 10. pii: 477942. doi: 10.1182/blood.2021010845.
PMID: 34758069